Biogen Wants MS Drug Approved Globally, CEO Says

April 15 (Bloomberg) -- George Scangos, chief executive officer of Biogen Idec Inc., talks about the drugmaker's first multiple sclerosis pill Tecfidera and the company's drug pipeline. He speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)

Bloomberg Markets: The Trump Economy 5/26
35:10 - Guests include: Eurasia Group's Ian Bremmer and Richard Haass of the Council on Foreign Relations. (Source: Bloomberg)
  • Wozniak on Apple's Path Toward a $1 Trillion Market Cap
  • Apple Co-Founder Wozniak on the Next Big Moonshots
  • FrontFour Nominates Granite Directors After Talks Fizzle